Review Article
Fecal Molecular Markers for Colorectal Cancer Screening
Table 3
Studies of the PreGen panel in the detection of genetic alterations in fecal samples.
| Authors and references | Markers | Specimen | Specimen = | Control = | Sensitivity | Specificity |
| Ahlquist et al. [32] | 15 markers: Kras, APC, p53, BAT26, DIA | CRC Adenoma | 22 11 | 28 | 91% 82% | 93% |
| Berger et al. [75] | 19 markers: p523, Kras, APC, BAT26 | CRC | 100 | None | 83% | NA |
| Berger et al. [76] | 19 markers: p53, APC, KRAS, BAT26 | Polyps ≥1 cm | 32 | None | 88% | NA |
| Tagore et al. [23] | 23 markers: full panel | Advanced CRC | 52 | 212 | 63.5% | 96.2% | Adenoma | 28 | 57.1% |
| Brand [36] | 23 markers: full panel | CRC | 16 | None | 69% | NA |
| Imperiale et al. [77] | 23 markers: full panel | CRC Adenoma | 31 40 | 1423 | 51.6% 32.5% | 94.4% |
| Syngal et al. [78] | 23 markers: full panel | CRC Adenoma | 68 23 | None | 63% 26% | NA |
|
|